Company news

Genomma Lab Internacional SAB de CV news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

LAB/B: Net sales fell 4.9% as FX and weak demand weighed, but LATAM growth and margin gains offset declines

April 23, 2026

LAB/B: Margins held strong despite sales decline, with recovery and growth initiatives set for 2026

February 26, 2026

LAB/B: Sales declined due to hyperinflation and weak demand, but margins and cost controls remained strong

October 23, 2025

LAB/B: Solid EBITDA margin and free cash flow growth offset weak sales and currency headwinds

July 24, 2025

LAB/B: Q1 2025 saw robust EBITDA and EPS growth, with strong cash flow and margin gains

May 2, 2025

LAB/B: Exceptional 2024 results: strong sales, record profits, margin expansion, and robust cash flow

February 27, 2025

LAB/B: Q3 delivered robust sales, margin, and cash flow growth, with strong outlook and disciplined capital use

October 24, 2024

LAB/B: Q2 2024 delivered strong profit growth, margin expansion, and strategic M&A activity

July 25, 2024

Calls

The 5 newest of 19 calls. Every call is listed under its year.

Decks

The 5 newest of 18 decks. Every deck is listed under its year.